OmicronResearch
Omicron Research
- Cell Reports: Structures of Omicron spike complexes and implications for neutralizing antibody development
- Saudi Journal of Biological Sciences: An in silico approach unveils the potential of antiviral compounds in preclinical and clinical trials as SARS-CoV-2 omicron inhibitors
- Biosafety and Health: Genetic differentiation and diversity of SARS-CoV-2 omicron variant in Its early outbreak
- American Journal of Obstetrics and Gynecology: Preserved recognition of Omicron Spike following COVID-19 mRNA vaccination in pregnancy
- JAMA Network: Vaccine Booster Dose Appears to Reduce Omicron Hospitalizations
- The Lancet: Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study
- The Lancet: New year, new SARS-CoV-2 variant: Resolutions on genomic surveillance protocols to face Omicron
- Clinical Infection in Practice: The emergence of the Omicron variant
- The Lancet: COVID-19 vaccine boosters in the Asia-Pacific region in the context of Omicron
- Advisory Board: Do omicron-specific boosters work better? What early research suggests
- Cell Reports: Cryo-EM structure of the SARS-CoV-2 omicron spike
- The Lancet: The allocation of COVID-19 vaccines and antivirals against emerging SARS-CoV-2 variants of concern in East Asia and Pacific region: A modelling study
- Cell: T-cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals
- Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose (The Lancet)
- The Lancet: Transmission of Omicron (B.1.1.529) - SARS-CoV-2 Variant of Concern in a designated quarantine hotel for travelers: a challenge of elimination strategy of COVID-19
- Understanding omicron (NewScientist)
- Omicron’s Message on Vaccines: Boosting Begets Breadth (CellPress)
- Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals (Journal of Infection)
- Regular and booster vaccination with inactivated vaccines enhance the neutralizing activity against Omicron variant both in the breakthrough infections or vaccinees (Journal of Infection)
- Receptor binding and complex structures of human ACE2 to spike RBD from Omicron and Delta SARS-CoV-2 (Journal of Infection)
- From delta to Omicron: S1-RBD/S2 mutation/deletion equilibrium in SARS-CoV-2 defined variants (Gene)
- Genomic perspectives on the emerging SARS-CoV-2 omicron variant (Genomics, Proteomics & Bioinformatics)
- The Lancet Voice: Listen to “Vaccination rates and Omicron in London.”
- Structural modeling of Omicron spike protein and its complex with human ACE-2 receptor: Molecular basis for high transmissibility of the virus (Biochemical and Biophysical Research Communications)
- mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant (Cell Press)
- SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses (Cell Press)
- Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies ... (International Journal of Infectious Diseases)
- The emergence of new SARS-CoV-2 variant (Omicron) and increasing calls for COVID-19 vaccine boosters-The debate continues (Travel Medicine and Infectious Disease)
- SARS-CoV-2 B.1.1.529 (Omicron) Variant in the United States (Morbidity and Mortality Weekly Report) via PracticeUpdate
